COVID-19 Self-testing IMPROVE

Temple University

Status: Completed

Conditions: COVID-19

Treatments: Behavioral: IMPROVE

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT06576167

RADxUP

Details and patient eligibility

About

The study aims to engage community partners to implement IMPROVE intervention and promote (COVID-19) rapid testing among vulnerable Asian Americans in the Greater Philadelphia Area and New York City

Enrollment: 1,271 patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• (1) self-identified as Asian from one of the subgroups: Chinese, Korean, Vietnamese, Filipino, or other South Asian Americans,
• (2) aged 18 and above,
• (3) living in the Greater Philadelphia or NYC areas,

Exclusion criteria

Trial design

Primary purpose: Screening

Allocation: Randomized

Interventional model: Sequential Assignment

Masking: None (Open label)

---

1,271 participants in 3 patient groups

Wedge 1

Experimental group

Description:

The earliest group to implement the IMPROVE intervention ( in 4-9 study months).

Treatment:

Behavioral: IMPROVE

Wedge 2

Experimental group

Description:

Following the wedge 1 group, the wedge 2 group started the intervention in the study months 7-12.

Treatment:

Behavioral: IMPROVE

Wedge 3

Experimental group

Description:

The wedge 3 group started the intervention in the study months 10-15.

Treatment:

Behavioral: IMPROVE